Skip to main content
Log in

Observations consistent with autocrine stimulation of hybridoma cell growth and implications for large-scale antibody production

  • Published:
Biotechnology Letters Aims and scope Submit manuscript

Abstract

Existence of autocrine growth factors (aGFs) may influence the serum requirement for growth of hybridoma cells and thus significantly influence process economics. For the murine hybridoma cell line S3H5/γ2bA2, critical inoculum density (cID) and serum requirement for growth were inversely related for cultivation in both T flasks and spinner flasks. In spinner flasks, an inoculum density of 106 cells/ml was necessary for the cells to grow in RPMI 1640 medium without serum supplement, and an inoculum density of 103 cell/ml was necessary in RPMI 1640 medium with 10% serum. In T flasks, where the local cell density is higher than in spinner flasks, an inoculum density of 106 cells/ml was necessary for the cells to grow in RPMI 1640 medium without serum supplement, and an inoculum density of 1 cell/ml was also necessary in RPMI 1640 medium with 10% serum. Further, immobilized cells at high local cell density could grow under conditions where cells in T flasks at corresponding overall cell density could not grow. The cells at high inoculum density were less sensitive to shear induced by mechanical agitation than the cells at low inoculum density. Taken together these observations support the existence of secreted aGF(s) by the hybridoma cell line used. Since the specific MAb production rate was independent of cultivation method and inoculum density, the existence of autocrine growth factors would suggest that the use of immobilized cells should improve the economics of MAb production.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Balkwill, F. R.Cytokines in Cancer Therapy. Oxford University Press: Oxford, 1989; pp. 174–181.

    Google Scholar 

  • Bergman, Y.; Haimovich, J.Eur. J. Immunol. 1977, 7, 413–417.

    Google Scholar 

  • Cooper, G. M.Oncogenes. Jones and Bartlett Publishers, Inc.: Boston, MA, 1990; pp 163–173.

    Google Scholar 

  • Dean, Jr., R. C.; Karkare, S. B.; Ray, N. G.; Rundstadier, Jr., P. W.; Venkatasubramanian, K.Ann. N. Y. Acad. Sci.,1987, 506, 129–146.

    Google Scholar 

  • Dodge, T. C.; Hu, W. S.Biotechnol. Lett. 1986, 8, 683–686.

    Google Scholar 

  • Hagedorn, J.; Kargi, F.Biotechnol. Prog.,1990, 6, 220–224.

    Google Scholar 

  • Heath, C.; Dilwith, R.; Belfort, G.J. Biotechnol. 1990, 15, 71–90.

    Google Scholar 

  • Hirano, T.; Yasukawa, K.; Harada, H.; Taga, T.; Watanabe, Y.; Matsuda, T.; Kashiwamura, S.; Nakajima, K.; Koyama, K.; Iwamatsu, A.; Tsunasawa, S.; Sakiyama, F.; Matsui, H.; Takahara, Y.; Taniguchi, T.; Kishimoto, T.Nature. 1986, 324, 73–76.

    Google Scholar 

  • Kiwano, M.; Hirano, T.; Matsuda, T.; Taga, T.; Horii, Y.; Iwato, K.; Asaoku, H.; Tang, B.; Tanabe, O.; Tanaka, H.; Kuramoto, A.; Kishimoto, T.Nature. 1988, 332, 83–85.

    Google Scholar 

  • Kunas, K. T.; Papoutsakis, E. T.;Biotechnol. Lett. 1989, 11, 525–530.

    Google Scholar 

  • Kunas, K. T.; Papoutsakis, E. T.J. Biotechnol.,1990, 15, 57–69.

    Google Scholar 

  • Lee, G. M.; Huard, T. K.; Palsson, B. O.Biotechnol. Lett. 1988, 10, 307–312.

    Google Scholar 

  • Lee, G. M.; Huard, T. K.; Kaminski, M. S.; Palsson, B. O.Biotechnol. Lett. 1988, 10, 625–628.

    Google Scholar 

  • Lee, G. M.; Huard, T. K.; Palsson, B. O.Hybridoma 1989, 8, 369–375.

    Google Scholar 

  • Lee, G. M.; Savinell, J. M.; Palsson, B. O.Hybridoma 1989, 8, 639–645.

    Google Scholar 

  • Lee, G. M.; Palsson, B. O.Biotechnol. Technique 1990, 4, 341–344.

    Google Scholar 

  • Lee, G. M.; Palsson, B. O.Biotechnol. Bioeng. 1990, 36, 1049–1055.

    Google Scholar 

  • Maiorella, B.; Howarth, B.; Shauger, A.; Inlow, D. Optimized pH control for antibody production. Presented at ACS National Meeting, Miami, FL, 1989.

  • McQueen, A.; Bailey, J. E.Biotechnol. Lett.,1989, 11, 531–536.

    Google Scholar 

  • Murakami, H.; Masui, H.; Sato, G. Suspension culture of hybridoma cells in serum-free medium: soybean phospholipids as essential components. InGrowth of Cells Hormonally Defined Media; G. Sato, A. Pardee, D. Sinbasku, Eds.: Cold Spring Harbour Laboratories, Cold Spring Harbour: New York, 1982; pp 711–715.

    Google Scholar 

  • Petersen, J. F.; McIntyre, L. V.; Papoutsakis, E. T.J. Biotechnol. 1988, 7, 229–246.

    Google Scholar 

  • Pol, L.; Zijlstra, G.; Thalen, M.; Tramper, J.Bioprocess Engr.,1990, 5, 241–245.

    Google Scholar 

  • Ozturk, S. S.; Palsson, B. O.J. Biotechnol. 1990, 16, 259–278.

    Google Scholar 

  • Reuveny, S.; Velez, D.; Miller, L.; MacMillan, J. D.J. Immunol. Methods,1986, 86, 61–69.

    Google Scholar 

  • Sakai, K.; Hattori, T.; Matsuoka, M.; Asou, N.; Yamamoto, S.; Sagawa, K.; Takatsuki, K.J. Exp. Med. 1987, 166, 1597–1602.

    Google Scholar 

  • Shacter, E.Trends Biotechnol.,1989, 7, 248–253.

    Google Scholar 

  • Sporn, M. B.; Roberts, A. B.Nature 1985, 313, 745–747.

    Google Scholar 

  • Tharakan, J. P.; Chau, P. C.Biotechnol. Lett. 1986, 8, 457–462.

    Google Scholar 

  • Velez, D.; Reuveny, S.; Miller, L.; Macmillan, J. D.J. Immunol. Methods 1986, 86, 45–52.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, G.M., Kaminski, M.S. & Palsson, B.O. Observations consistent with autocrine stimulation of hybridoma cell growth and implications for large-scale antibody production. Biotechnol Lett 14, 257–262 (1992). https://doi.org/10.1007/BF01022320

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01022320

Keywords

Navigation